购物车
- 全部删除
- 您的购物车当前为空
Brimarafenib是一种选择性RAF二聚体抑制剂,能够抑制BRAF和CRAF的活性,对多种RAF突变(包括BRAF I/II/III突变、BRAF融合和CRAF异二聚化)表现出显著的抑制效果,用于治疗结直肠癌、胰腺癌等MAPK突变的实体瘤。
为众多的药物研发团队赋能,
让新药发现更简单!
Brimarafenib是一种选择性RAF二聚体抑制剂,能够抑制BRAF和CRAF的活性,对多种RAF突变(包括BRAF I/II/III突变、BRAF融合和CRAF异二聚化)表现出显著的抑制效果,用于治疗结直肠癌、胰腺癌等MAPK突变的实体瘤。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,330 | 现货 | |
5 mg | ¥ 2,930 | 现货 | |
10 mg | ¥ 4,397 | 现货 | |
25 mg | ¥ 7,476 | 现货 | |
50 mg | ¥ 11,210 | 现货 |
产品描述 | Brimarafenib is a selective RAF dimerization inhibitor, which can inhibit the activity of BRAF and CRAF, and exhibits significant inhibitory effects on a variety of RAF mutations (including BRAF I/II/III mutations, BRAF fusion and CRAF heterodimerization), and is used for the treatment of colorectal and pancreatic cancers and other solid tumors with MAPK mutations. |
别名 | 布利马拉非尼布, Brimarafenibum, BGB-3245, BGB3245, BGB245, BGB 245 |
分子量 | 482.41 |
分子式 | C24H17F3N4O4 |
CAS No. | 1643326-82-2 |
Smiles | N(C(NC1=C(F)C=C(F)C(F)=C1)=O)[C@H]2[C@]3([C@@]2(OC=4C3=CC(OC5=C6C(NC=C5)=NC(=O)CC6)=CC4)[H])[H] |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容